| You are visitor 52 |
Wednesday March 10, 2010
![]() |
International Pharmaceutical Academy (IPA) is a progressive Canadian organization dedicated to be the primary provider of Quality Education and Training for the Pharmaceutical, Medical Devices, Biologics, Cosmetics, and Allied Industries.
We present experts from industry, academia and government agencies. Providing the best in educational instruction in short course formats together with carefully orchestrated workshops.
![]() |
![]() |
![]() |
![]() |
![]() |
March 23-24, 2010 | Somerset, NJ - USA
Conference Topics
| More details... |
April 14-15, 2010 - Montreal, Canada
Identify opportunities to improve your internal audit activity's ability to add value and improve operations - and develop actions to move forward on the path to quality
This two-day "hands on" training course & workshops will address various topics, techniques, tools and methods for auditing including:
| More details... |
March 24 - 25, 2010 | Toronto, Canada
A Two day comprehensive course with workshops on:
| More details... |
April 14-15, 2010 - Montreal, Canada
Featuring In-Depth Presentations, Case-Studies & Workshops on:
Workshop
Interactive Exercises
| More details... |
March 30-31, 2010 - Somerset, NJ, USA
A Two-day interactive course with workshops, case studies and Interactive exercises on:
| More details... |

Health Canada is advising expectant mothers and breastfeeding women not to take the vitamin-mineral supplements Maxum Matragen or Maxum Multi-Vite by Seroyal International Inc. Maxum Multi-Vite has been approved as a vitamin-mineral supplement for only the general public but lacks the required cautionary statement on the label regarding pregnant and/or breast feeding women. The product Maxum Matragen is being promoted by the company as a prenatal supplement; however, neither product has been authorized for sale by Health Canada for use by women who are pregnant or breastfeeding. Read More
Health Canada is warning consumers that there is a small possibility that some bottles of one lot of Rofact® (rifampin), an antibiotic used to treat tuberculosis (TB) and some other infections, may contain the drug clonazepam instead of the antibiotic rifampin. The affected lot number of Rofact® is 8K5467, and the Drug Identification Number (DIN) is 00343617. Clonazepam is an anti-epileptic medication and has sedating properties. The manufacturer, Valeant Canada, is initiating a recall to the retail level. Read More
Health Canada is updating Canadians about Hydroxycut products. On May 1, 2009, the U.S. Food and Drug Administration (FDA) issued a public warning regarding certain Hydroxycut products. The FDA is advising U.S. consumers to stop using Hydroxycut products as there have been reports of liver injuries potentially associated with this product in the United States. Read More